SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-15-088298
Filing Date
2015-03-12
Accepted
2015-03-12 07:50:39
Documents
16
Period of Report
2015-03-06
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d885387d8k.htm 8-K 17071
2 EX-10.1 d885387dex101.htm EX-10.1 554528
3 EX-99.1 d885387dex991.htm EX-99.1 10887
4 GRAPHIC g8853870038.jpg GRAPHIC 192071
5 GRAPHIC g8853870040.jpg GRAPHIC 172568
6 GRAPHIC g8853871.jpg GRAPHIC 220349
7 GRAPHIC g8853872.jpg GRAPHIC 227771
8 GRAPHIC g8853873.jpg GRAPHIC 225307
9 GRAPHIC g8853873700.jpg GRAPHIC 139404
10 GRAPHIC g8853874.jpg GRAPHIC 232122
11 GRAPHIC g8853875.jpg GRAPHIC 233983
12 GRAPHIC g8853876.jpg GRAPHIC 137253
13 GRAPHIC g885387ex10_1pg41.jpg GRAPHIC 157440
14 GRAPHIC g885387ex10_1pg42.jpg GRAPHIC 235352
15 GRAPHIC g885387g78d03.jpg GRAPHIC 228762
16 GRAPHIC g885387gra.jpg GRAPHIC 9742
  Complete submission text file 0001193125-15-088298.txt   3909038
Mailing Address 4960 PEACHTREE INDUSTRIAL BOULEVARD SUITE 240 NORCROSS GA 30071
Business Address 4960 PEACHTREE INDUSTRIAL BOULEVARD SUITE 240 NORCROSS GA 30071 678-620-3186
GALECTIN THERAPEUTICS INC (Filer) CIK: 0001133416 (see all company filings)

IRS No.: 043562325 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-31791 | Film No.: 15694423
SIC: 2834 Pharmaceutical Preparations